Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women.
Chapuy
M C
MC
Institut National de la Santé et de la Recherche Médicale U 234, Hôpital Edouard Herriot, Lyons, France.
Arlot
M E
ME
Delmas
P D
PD
Meunier
P J
PJ
D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D002130:Calcium Phosphates / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005265:Femoral Neck Fractures / Q000378:metabolism; D005500:Follow-Up Studies; D006620:Hip Fractures / Q000517:prevention & control*; D006801:Humans; D008159:Lumbar Vertebrae / Q000378:metabolism; D012307:Risk Factors
D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D002762:Cholecalciferol; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous